Background: Closure time (CT), measured by platelet function analyzer (PFA-100((R))) device, is now available to the clinical laboratory as a possible alternative or supplement to the bleeding time test. Aim: On behalf of the Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH-SSC), a working Group was formed to review and make recommendations on the use of the PFA-100 CT in the evaluation of platelet function within the clinical laboratory. Methods: The Medline database was searched to review the published information on the PFA-100 CT in the evaluation of platelet disorders and platelet function. This information, and expert opinion, was used to prepare a report and generate consensus recommendations. Results: Although the PFA-100 CT is abnormal in some forms of platelet disorders, the test does not have sufficient sensitivity or specificity to be used as a screening tool for platelet disorders. A role of the PFA-100 CT in therapeutic monitoring of platelet function remains to be established. Conclusions: The PFA-100 closure time should be considered optional in the evaluation of platelet disorders and function, and its use in therapeutic monitoring of platelet function is currently best restricted to research studies and prospective clinical trials.

Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function / C.P. Hayward, P. Harrison, M. Cattaneo, T.L. Ortel, A.K. Rao. - In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. - ISSN 1538-7933. - 4:2(2006), pp. 312-319. [10.1111/j.1538-7836.2006.01771.x]

Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function

M. Cattaneo;
2006

Abstract

Background: Closure time (CT), measured by platelet function analyzer (PFA-100((R))) device, is now available to the clinical laboratory as a possible alternative or supplement to the bleeding time test. Aim: On behalf of the Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH-SSC), a working Group was formed to review and make recommendations on the use of the PFA-100 CT in the evaluation of platelet function within the clinical laboratory. Methods: The Medline database was searched to review the published information on the PFA-100 CT in the evaluation of platelet disorders and platelet function. This information, and expert opinion, was used to prepare a report and generate consensus recommendations. Results: Although the PFA-100 CT is abnormal in some forms of platelet disorders, the test does not have sufficient sensitivity or specificity to be used as a screening tool for platelet disorders. A role of the PFA-100 CT in therapeutic monitoring of platelet function remains to be established. Conclusions: The PFA-100 closure time should be considered optional in the evaluation of platelet disorders and function, and its use in therapeutic monitoring of platelet function is currently best restricted to research studies and prospective clinical trials.
von-Willebrand-disease; high-shear stress; percutaneous coronary intervention; template bleeding-time; in-vitro; primary hemostasis; aspirin resistance; PFA-100(TM) system; healthy volunteers; dysfunction
Settore MED/09 - Medicina Interna
2006
Article (author)
File in questo prodotto:
File Dimensione Formato  
j.1538-7836.2006.01771.x.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 127.69 kB
Formato Adobe PDF
127.69 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/38656
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus 367
  • ???jsp.display-item.citation.isi??? 304
social impact